Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 10/20 | 0.55 |
| ▸ | CNR2 | P34972 | 9/20 | 0.54 |
| ▸ | CNR1 | P21554 | 5/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.54 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.54 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.54 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.54 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.54 |
| ▸ | GPR6 | P46095 | 1/20 | 0.54 |
| ▸ | NAAA | Q02083 | 1/20 | 0.54 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.54 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.54 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.54 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 0.54 |
| ▸ | MLNR | O43193 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23801221 | 1.00 | OPRM1 (0.55) | OPRM1CNR2CNR1TRPV1CYP1A1 | |
| SCHEMBL16917913 | 1.00 | OPRM1 (0.55) | OPRM1CNR2CNR1TRPV1CYP1A1 | |
| SCHEMBL22564623 | 1.00 | OPRM1 (0.55) | OPRM1CNR2CNR1TRPV1CYP1A1 | |
| SCHEMBL13214083 | 0.91 | OPRM1 (0.68) | OPRM1CNR2CNR1TRPV1CYP1A1 | |
| SCHEMBL23868462 | 0.91 | OPRM1 (0.68) | OPRM1CNR2CNR1TRPV1CYP1A1 | |
| SCHEMBL16084557 | 0.91 | OPRM1 (0.68) | OPRM1CNR2CNR1TRPV1CYP1A1 | |
| SCHEMBL31545434 | 0.78 | OPRM1 (0.51) | OPRM1CNR2CNR1TRPV1CYP1A1 | |
| SCHEMBL25560752 | 0.78 | OPRM1 (0.51) | OPRM1CNR2CNR1TRPV1CYP1A1 | |
| SCHEMBL25560749 | 0.78 | OPRM1 (0.51) | OPRM1CNR2CNR1TRPV1CYP1A1 | |
| SCHEMBL22910025 | 0.76 | OPRM1 (0.64) | OPRM1CNR2CNR1TRPV1CYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017091764-A1 | CANNABIS OIL COMPOSITIONS AND METHODS FOR PREPARATION THEREOF | CONSTANCE THERAPEUTICS, INC. (US) | 2017-06-01 | — | — | WO | disclosed |
| US-20160346339-A1 | METHODS FOR PREPARATION OF CANNABIS OIL EXTRACTS AND COMPOSITIONS | CONSTANCE THERAPEUTICS, INC. (US) | 2016-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160346339-A1 | METHODS FOR PREPARATION OF CANNABIS OIL EXTRACTS AND COMPOSITIONS | CNR2, CNR1, EPHX2 | OPRM1 1328/4885CNR2 1/4885CNR1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.